serotonin

(redirected from Selective serotonin reuptake inhibitors)
Also found in: Dictionary, Medical, Encyclopedia.
Related to Selective serotonin reuptake inhibitors: fluoxetine, citalopram, Tricyclic antidepressants, Monoamine oxidase inhibitors
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for serotonin

a neurotransmitter involved in e

References in periodicals archive ?
Selective Serotonin Reuptake Inhibitors (SSRIs) are used to treat severe or persistent depression by elevating the extracellular levels of serotonin.
Similar to our case, if "decreased positive effect" symptoms occur, and some residual symptoms or side effects are observed following the treatment with selective serotonin reuptake inhibitors (SSRIs) or selective noradrenaline reuptake inhibitors (SNRIs), the addition of bupropion to previous SSRI or SNRI treatment or switching to bupropion treatment have been reported to be beneficial (4).
However, the most prescribed classes of drugs in the therapy of depression remain the selective serotonin reuptake inhibitors and the dual reuptake inhibitors of serotonin and norepinephrine, even if part of the data asserts that only 50% of the patients treated with one of these two classes show proof of clinical remission (2).
Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.
Among them, citalopram, fluoxetine, and paroxetine belong to selective serotonin reuptake inhibitors (SSRIs), first-line therapeutic agents for treating a wide range of psychiatric disorders such as major depression, generalized anxiety disorder and post-traumatic disorder, to name but a few.
Improvement with a dose increase is somewhat at odds with the known mechanism of action of selective serotonin reuptake inhibitors (SSRIs), which are thought to have a flat dose-response curve.
The Question: Does taking selective serotonin reuptake inhibitors (SSRIs), used to treat depression, affect fetal growth during the first year of life?
Selective serotonin reuptake inhibitors (SSRIs) are the mainstay of pharmacological treatment for both depression and anxiety disorders.
Major Finding: ALKS 5461 showed rapid efficacy in 32 patients with major depressive disorder who failed to respond adequately to treatment with selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors.
All had failed to respond adequately to treatment with selective serotonin reuptake inhibitors (SSRIs) or selective serotonin-norepinephrine reuptake inhibitors (SNRIs), he said.
Serotonin is the target of the popular antidepressants known as selective serotonin reuptake inhibitors (SSRIs), which prolong the effect of serotonin in the brain.
Of these, 55 percent were for selective serotonin reuptake inhibitors (SSRIs), 32 percent for tricyclic antidepressants (TCAs), and 13.5 percent for "other" antidepressants.
Selective serotonin reuptake inhibitors (SSRIs) are more likely to cause death and issues such as heart attack, stroke, falls and seizures than older tricyclic antidepressants (TCAs), according to a study published in the British Medical Journal (BMJ).
"Although the number of children exposed prenatally to selective serotonin reuptake inhibitors in this population was low, results suggest that exposure, especially during the first trimester, may modestly increase the risk of ASD," the authors concluded.
Commonly used anti-inflammatory pain medications such as aspirin, ibuprofen, and naproxen may blunt the effectiveness of antidepressant drugs known as SSRIs (selective serotonin reuptake inhibitors).
Full browser ?